X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
100
PharmaCompass offers a list of Semaxanib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Semaxanib manufacturer or Semaxanib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Semaxanib manufacturer or Semaxanib supplier.
PharmaCompass also assists you with knowing the Semaxanib API Price utilized in the formulation of products. Semaxanib API Price is not always fixed or binding as the Semaxanib Price is obtained through a variety of data sources. The Semaxanib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Su 5416 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Su 5416, including repackagers and relabelers. The FDA regulates Su 5416 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Su 5416 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Su 5416 supplier is an individual or a company that provides Su 5416 active pharmaceutical ingredient (API) or Su 5416 finished formulations upon request. The Su 5416 suppliers may include Su 5416 API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Su 5416 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Su 5416 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Su 5416 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Su 5416 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Su 5416 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Su 5416 suppliers with NDC on PharmaCompass.
Su 5416 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Su 5416 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Su 5416 GMP manufacturer or Su 5416 GMP API supplier for your needs.
A Su 5416 CoA (Certificate of Analysis) is a formal document that attests to Su 5416's compliance with Su 5416 specifications and serves as a tool for batch-level quality control.
Su 5416 CoA mostly includes findings from lab analyses of a specific batch. For each Su 5416 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Su 5416 may be tested according to a variety of international standards, such as European Pharmacopoeia (Su 5416 EP), Su 5416 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Su 5416 USP).
Market Place
